360°
Spreadsheet
The post-US election rally continued into the new week, though only partially. The Dow rose another 0.68% or 300 points to a new high of almost 44,300 while the TSX advanced 0.12% nearly its own new high. TSX sectors were split, with tech and financials offsetting losses in materials and health care.
Major movers on Bay Street were Onex up 6.53%, Kinross Gold -9.62%, B2Gold -4.62%, BlackBerry 4.31% and Lightspeed 4.09%. Gold slid 2.3% to US$2,622 while WTI crude slipped over 3% to US$68.25.
On Wall Street, the S&P and Nasdaq were flat as drug companies dominated headlines. AbbVie tumbled 12.57% after it announced disappointing trial results of its schizophrenia drug. In contrast, Bristol-Myers Squibb‘s stock rocketed 10.49% on the news, driven by the strength of its rival drug, already approved by the FDA. Other notables included Albemarle, rallying 9.67%, Tesla 8.96% and Moderna -8.71%. Bitcoin continued its run by leaping 10% to US$87,925. Finally, the U.S. 10-year yield hovered at 4.3%.
🏛 Onex Corp (ONEX-T) +6.53%
🥇 Kinross Gold (K-T) -9.62%
🥇 B2Gold Corp. (BTO-T) -4.62%
📱 BlackBerry (BB-T) +4.31%
💾 Lightspeed Commerce Inc (LSPD-T) +4.09%
💊 AbbVie Inc. (ABBV-N) -12.57%
💊 Bristol Myers Squibb (BMY-N) +10.49%
⛏ Albemarle Corp (ALB-N) +9.67%
🚗 Tesla Inc (TSLA-Q) +8.96%
💉 Moderna (MRNA-Q) -8.71%
🅱 Bitcoin (BTCUSD) (CRYPTO:BTC) +10%
